1. Novel biomarker-driven trial of a cell and gene therapy for the treatment of malignant pleural mesothelioma (MPM): the STRATEGIC trial. (January 2020) Authors: Davies, A.; Sage, B.; Kolluri, K.; Graham, R.; Alrifai, D.; Weil, B.; Patrick, P.S.; Champion, K.; Day, A.; Popova, B.; Wheeler, G.; Fullen, D.; Kalber, T.; Lowdell, M.; Janes, S.; Forster, M. Journal: Lung cancer Issue: Volume 139(2020)Supplement 1 Page Start: S70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗